KK
KYMR icon

KLP Kapitalforvaltning’s Kymera Therapeutics KYMR Stock Holding History

KLP Kapitalforvaltning’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Hold
10,500
– – ﹤0.01% 1019
2026
Q1 		$875K Buy
10,500
+300
+3% +$23.8K ﹤0.01% 1109
2025
Q4 		$794K Buy
10,200
+1,200
+13% +$81K ﹤0.01% 1161
2025
Q3 		$509K Buy
9,000
+1,300
+17% +$58.6K ﹤0.01% 1383
2025
Q2 		$336K Hold
7,700
– – ﹤0.01% 1547
2025
Q1 		$211K Hold
7,700
– – ﹤0.01% 1726
2024
Q4 		$310K Buy
+7,700
New +$348K ﹤0.01% 1624

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KLP Kapitalforvaltning's KYMR Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 10,500 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1019.

KLP Kapitalforvaltning first reported a position in KYMR in Q4 2024 and has held it in 7 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • KLP Kapitalforvaltning held 10,500 shares of Kymera Therapeutics worth $1.2M as of Q2 2026.
  • KLP Kapitalforvaltning left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1019 holding.
  • KLP Kapitalforvaltning first reported a position in Kymera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.